Tensions surrounding the use of inhaled asthma medication in The Gambia: a qualitative study of asthma patients and health care workers
Author:
Affiliation:
1. University of Sheffield
2. Medical Research Council at London School of Tropical Medicine and Hygiene
3. Permian Health Lung Institute
4. University of Cambridge
5. Canterbury Christ Church University
Abstract
Introduction: Asthma-related mortality is high in low- and middle-income countries. Little is known about public perceptions of inhaled medicines. Methods: We conducted semi-structured interviews with asthma patients and health care workers at three public health facilities in The Gambia, between August and November 2022. Thematic analysis was used to interpret these data. Results: A total of 20 patients and 15 health care workers were interviewed. Both groups felt limited access to inhalers was a significant issue resulting in continued use of oral medications. While some patients recognised the benefits of inhaler use, beliefs that inhalers were dangerous were common. Reliance on oral short-acting beta agonists meant patients saw asthma as a recurrent acute condition resulting in an emphasis on hospital management with little awareness of inhaled preventative medicines. Discussion: Increasing access to inhaled medicines has the potential to save lives but socio-cultural factors in addition to medication supply need addressing.
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019;Vos T;The Lancet,2020
2. The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study;Mortimer K;Eur Respir J,2022
3. The burden of asthma, hay fever and eczema in children in 25 countries: GAN Phase I study;García-Marcos L;Eur Respir J,2022
4. Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study;Asher MI;The Lancet,2021
5. The Global Asthma Report 2022. Int J Tuberc Lung Dis. 2022;26(1):1–104.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3